Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Agnosia × Dosage Forms × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 3 Leukemia 3 Vomiting 2 Stomach Neoplasms 2 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Urologic Neoplasms 1 Urogenital Neoplasms 1 Substance-Related Disorders 1 Solid Tumors 1 Pancreatic Neoplasms 1 Opioid-Related Disorders 1 Opioid-Induced Constipation 1 Neurofibromatosis 1 1 Neoplasms 1 Myelodysplastic Syndromes 1 Motor Activity 1 Lymphoma, Follicular 1 Lymphoma 1 Low Anterior Resection Syndrome 1 Kidney Neoplasms 1 Hematologic Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Renal Cell 1 Cancer Pain 1 Breast Neoplasms 1 Agnosia 1 Advanced Solid Tumors 1

Interventions

Bupivacaine 9 Ketamine 8 Ropivacaine 6 Fentanyl 6 Dexmedetomidine 6 Anesthesia, General 6 Acetaminophen 6 Morphine 5 Lidocaine 5 Analgesics, Opioid 5 Acupuncture Therapy 5 Pregabalin 4 Ethanol 4 Anesthesia, Local 4 parecoxib 3 Tramadol 3 Sodium Chloride 3 Saline Solution 3 Propofol 3 Ketorolac 3 Control Groups 3 Anesthetics, Local 3 Analgesia, Epidural 3 trimebutine 3-thiocarbamoylbenzenesulfonate 2 Transcutaneous Electric Nerve Stimulation 2 Surveys and Questionnaires 2 Radiofrequency Ablation 2 Magnesium Sulfate 2 Levobupivacaine 2 Injections, Epidural 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02718404 2022-06-30

HIFU-Bone

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

Phase NA Terminated

Agnosia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡